Cargando…

Comprehensive Comparison of the Effect of Inotropes on Cardiorenal Syndrome in Patients with Advanced Heart Failure: A Network Meta-Analysis of Randomized Controlled Trials

Prevention of cardiorenal syndrome through treatment with inotropic agents remains challenging. This network meta-analysis evaluated the safety and renoprotective effects of inotropes on patients with advanced heart failure (HF) using a frequentist random-effects model. A systematic database search...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Wei-Cheng, Lin, Meng-Hsuan, Chen, Chieh-Lung, Lai, Yi-Ching, Chen, Chih-Yu, Lin, Yu-Chao, Hung, Chin-Chuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471363/ https://www.ncbi.nlm.nih.gov/pubmed/34575231 http://dx.doi.org/10.3390/jcm10184120

Ejemplares similares

Comprehensive Comparisons among Inotropic Agents on Mortality and Risk of Renal Dysfunction in Patients Who Underwent Cardiac Surgery: A Network Meta-Analysis of Randomized Controlled Trials
por: Chen, Wei-Cheng, et al.
Publicado: (2021)

Inotropes do not increase mortality in advanced heart failure
por: Guglin, Maya, et al.
Publicado: (2014)

Long‐term administration of intravenous inotropes in advanced heart failure
por: Gentile, Piero, et al.
Publicado: (2021)

Cardiorenal biomarkers in acute heart failure
por: Choudhary, Rajiv, et al.
Publicado: (2012)

Association between the risk of heart failure hospitalization and end-stage renal disease with digoxin usage in patients with cardiorenal syndrome: A population-based study
por: Chang, Kai-Ting, et al.
Publicado: (2023)

Use of Inotropic Agents in Treatment of Systolic Heart Failure
por: Tariq, Sohaib, et al.
Publicado: (2015)

Cardiorenal Syndrome in Acute Heart Failure Syndromes
por: Sarraf, Mohammad, et al.
Publicado: (2011)

Intermittent inotropic therapy with levosimendan vs. milrinone in advanced heart failure patients
por: Milwidsky, Assi, et al.
Publicado: (2022)

Effects of Widespread Inotrope Use in Acute Heart Failure Patients
por: Kang, Jeehoon, et al.
Publicado: (2018)

Efficacy of the New Inotropic Agent Istaroxime in Acute Heart Failure
por: Forzano, Imma, et al.
Publicado: (2022)

Advanced heart failure: guideline‐directed medical therapy, diuretics, inotropes, and palliative care
por: Tomasoni, Daniela, et al.
Publicado: (2022)

Inotropes and Inodilators for Acute Heart Failure: Sarcomere Active Drugs in Focus
por: Nagy, László, et al.
Publicado: (2014)

Comparison of Positive Inotropic Agents in the Management of Acute Decompensated Heart Failure
por: Kelly, Julie, et al.
Publicado: (2020)

Role of Pulsatile Hemodynamics in Acute Heart Failure: Implications for Type 1 Cardiorenal Syndrome
por: Sung, Shih-Hsien, et al.
Publicado: (2013)

Intermittent inotropic support with levosimendan in advanced heart failure as destination therapy: The LEVO‐D registry
por: Dobarro, David, et al.
Publicado: (2023)

On inotropic effects of UTP in the human heart
por: Neumann, J., et al.
Publicado: (2019)

Improving Prognosis Estimation in Patients with Heart Failure and the Cardiorenal Syndrome
por: Abdel-Qadir, Husam M., et al.
Publicado: (2011)

New roles for renin and prorenin in heart failure and cardiorenal crosstalk
por: Schroten, Nicolas F., et al.
Publicado: (2011)

Cardiorenal Syndrome Caused by Heart Failure with Preserved Ejection Fraction
por: Lazzeri, Chiara, et al.
Publicado: (2011)

Cardiorenal Syndrome: Role of Arginine Vasopressin and Vaptans in Heart Failure
por: Vinod, Poornima, et al.
Publicado: (2017)

Cardiorenal Effects of Long‐Term Phosphodiesterase V Inhibition in Pre–Heart Failure
por: Hubers, Scott A., et al.
Publicado: (2022)

Prognosis and risk stratification in patients with decompensated heart failure receiving inotropic therapy
por: Gomes, Clara, et al.
Publicado: (2018)

Vasopressor stays vasopressor and inotrope stays inotrope!
por: Luckner, Günter, et al.
Publicado: (2008)

Is Exercise Training Appropriate for Patients With Advanced Heart Failure Receiving Continuous Inotropic Infusion? A Review
por: Amiya, Eisuke, et al.
Publicado: (2018)

Fractional Excretion of Urate for Diuresis Management in Heart Failure and Cardiorenal Syndrome
por: Berger, Amnon A., et al.
Publicado: (2021)

Agents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyond
por: Teerlink, John R., et al.
Publicado: (2009)

Probenecid: An Oral Inotrope for End-Stage Heart Failure in a Case With Myotonic Dystrophy
por: Klein, Evan C., et al.
Publicado: (2019)

Positive inotropic action of insulin on piglet heart.
por: Rieker, R. P., et al.
Publicado: (1975)

Corticosteroids reduce inotrope requirements in hypotensive liver failure
por: Harry, R, et al.
Publicado: (2001)

Vasopressin Is No Inotrope
por: Roeleveld, Peter Paul
Publicado: (2018)

Expected vs Actual Outcomes of Elective Initiation of Inotropic Therapy During Heart Failure Hospitalization
por: Snipelisky, David, et al.
Publicado: (2020)

Inotropes in Acute Heart Failure: From Guidelines to Practical Use: Therapeutic Options and Clinical Practice
por: Bistola, Vasiliki, et al.
Publicado: (2019)

Hemodynamic effects of inotropic drugs in heart failure: A network meta-analysis of clinical trials
por: Long, Ling, et al.
Publicado: (2019)

Angiotensin receptor neprilysin inhibitor in inotrope dependent heart failure patients: A case series
por: Taghavi, Sepideh, et al.
Publicado: (2020)

Case report: Denosumab-associated acute heart failure in patients with cardiorenal insufficiency
por: Xing, Yuexian, et al.
Publicado: (2022)

Total inotrope exposure score: an extension of the vasoactive inotrope score
por: Bangalore, H, et al.
Publicado: (2015)

Right Heart Function in Cardiorenal Syndrome
por: Kramer, Tilmann, et al.
Publicado: (2022)

Optimal Heart Rate Control Improves Long-Term Prognosis of Decompensated Heart Failure with Reduced Ejection Fraction
por: Tsai, Ming-Lung, et al.
Publicado: (2023)

Circulating biomarker responses to medical management vs. mechanical circulatory support in severe inotrope‐dependent acute heart failure
por: Meredith, Anna J., et al.
Publicado: (2015)

Why has positive inotropy failed in chronic heart failure? Lessons from prior inotrope trials
por: Ahmad, Tariq, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_sf6hnipb228tl8o312gng3qo95